Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome is characterized by nonprogressive spastic paraplegia, retinitis pigmentosa, and intellectual deficit. It has been described in two brothers born to consanguineous parents.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome.
97 publications have been identified in PubMed for spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome. Kisho has analyzed 31 by research type. Research spans Review / Meta-Analysis (32%), Basic Science / Preclinical (29%), and Case Report / Case Series (23%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 10 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 1:17 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 9 | 29% |
Patient case studies | 7 | 23% |
Disease patterns and progression | 4 | 13% |
Clinical study results | 1 | 3% |
Serpieri V (2026). [PMID: 41720098](https://pubmed.ncbi.nlm.nih.gov/41720098/). *Am J Hum Genet*. [Basic Science / Preclinical]
Hoskovcova M (2026). [PMID: 41909919](https://pubmed.ncbi.nlm.nih.gov/41909919/). *Mov Disord*. [Review / Meta-Analysis]
Bruschi F (2026). [PMID: 41144879](https://pubmed.ncbi.nlm.nih.gov/41144879/). *Mov Disord*. [Clinical Trial Publication]
Lang LS (2026). [PMID: 41717397](https://pubmed.ncbi.nlm.nih.gov/41717397/). *Pain Rep*. [Review / Meta-Analysis]
Burlina A (2025). [PMID: 40237972](https://pubmed.ncbi.nlm.nih.gov/40237972/). *Neurol Sci*. [Review / Meta-Analysis]
Mertiri L (2025). [PMID: 41320772](https://pubmed.ncbi.nlm.nih.gov/41320772/). *J Neuroimaging*. [Review / Meta-Analysis]
Buianova AA (2025). [PMID: 40189573](https://pubmed.ncbi.nlm.nih.gov/40189573/). *Neurol Res Pract*. [Case Report / Case Series]
Belot A (2025). [PMID: 40374386](https://pubmed.ncbi.nlm.nih.gov/40374386/). *Rev Med Interne*. [Review / Meta-Analysis]
Erdogan EN (2025). [PMID: 40317680](https://pubmed.ncbi.nlm.nih.gov/40317680/). *Am J Med Genet A*. [Basic Science / Preclinical]
Damásio J (2025). [PMID: 41357347](https://pubmed.ncbi.nlm.nih.gov/41357347/). *Neurol Genet*. [Epidemiology / Natural History]